Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non-Small-Cell Lung Cancer: The NVALT-4 Study
Groen, H. J. M., Sietsma, H., Vincent, A., Hochstenbag, M. M. H., van Putten, J. W. G., van den Berg, A., Dalesio, O., Biesma, B., Smit, H. J. M., Termeer, A., Hiltermann, T. J. N., van den Borne, B.Volume:
29
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2011.35.5214
Date:
November, 2011
File:
PDF, 177 KB
english, 2011